EMERGENCY 20

Posted By admin On 25.03.21

Part 1. Overview Information

National Institutes of Health (NIH)

EMERGENCY 20 brings 10 of the best missions from 20 years of EMERGENCY to your PC - using current technology! Additionally it features EMERGENCY 5, EMERGENCY 2016 and EMERGENCY 2017 with all the campaigns, multiplayer maps and freeplay modes! The requirements of Section 2 of this Emergency Order supersede and replace Section 3 of Emergency Order 20-12 in its entirety; any references to Section 3 of Emergency Order 20-12 shall be deemed to refer to Section 2 of this Emergency Order. Except as superseded, all Broward County Emergency Orders remain in full force and effect. EXECUTIVE ORDER NUMBER 20-52 (Emergency Management -COVID-19 Public Health Emergency) WHEREAS, Novel Coronavirus Disease 2019 (COVID-19) is a severe acute respiratory illness that can spread among humans through respiratory transmission and presents with symptoms similar to those of influenza;.

National Cancer Institute (NCI)

National Center for Complementary and Integrative Health (NCCIH)

National Eye Institute (NEI)

National Human Genome Research Institute (NHGRI)

National Institute of Allergy and Infectious Diseases (NIAID)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Emergency 20 Download

National Institute of Environmental Health Sciences (NIEHS)

National Institute of General Medical Sciences (NIGMS)
National Institute of Mental Health (NIMH)
National Institute of Drug Abuse ( NIDA )
National Institute on Minority Health and Health Disparities (NIMHD)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Office of Strategic Coordination ( Common Fund )
National Center for Advancing Translational Sciences (NCATS)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute on Aging ( NIA )
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Library of Medicine (NLM)
National Institute of Nursing Research (NINR)
Office of Research on Women's Health (ORWH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Dental and Craniofacial Research ( NIDCR )

Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)

Emergency Notices of Special Interest (NOSIs) issued by the respective ICs will specify the activity codes under which recipients can apply.

New

November 25, 2020 - Limited Competition for Emergency Competitive Revisions For Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 from Skin and the Oral Cavity for Rapid Acceleration of Diagnostics Radical (RADx-rad). See Notice NOT-OD-21-035.
November 17, 2020 - Notice of Special Interest (NOSI): Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and their Communities. See Notice NOT-ES-21-002.
August 6, 2020 - Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Chemosensory Testing as a COVID-19 Screening Tool. See Notice NOT-OD-20-152.
August 6, 2020 - Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Wastewater Surveillance Research for Public Health Response to Coronavirus Disease 2019 (COVID-19). See Notice NOT-OD-20-159.
July 30, 2020 - Notice of NIDCR's Participation in PA-20-135. See Notice NOT-DE-20-030.
July 24, 2020 - Notice of NHLBI Participation in NOT-OD-20-121 . See Notice NOT-HL-20-805.
July 24, 2020 - Notice of NHLBI Participation in NOT-OD-20-119 . See Notice NOT-HL-20-803.
July 24, 2020 - Notice of Expiration of NOT-HL-20-782. See Notice NOT-HL-20-800.
July 6, 2020 - Notice of NIAMS Participation in PA-20-135. See Notice NOT-AR-20-020.
July 6, 2020 - Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). See Notice NOT-AI-20-059.
June 19, 2020 - Notice of NEI's Participation in PA-20-135. See Notice NOT-EY-20-010.
June 12, 2020 – Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations. See Notice NOT-OD-20-119 .
June 8, 2020 - Notice of Participation of National Institute of Nursing Research (NINR) in PA-20-135. See Notice NOT-NR-20-005.
June 8, 2020 - Notice of NIMH Participation in PA-20-135. See Notice NOT-MH-20-064.
June 8, 2020 - Notice of NLM's Participation in PA-20-135. See Notice NOT-LM-20-012.
June 5, 2020 - Notice of ORWH Participation in PA-20-135. See Notice NOT-OD-20-111.
June 5, 2020 - Notice of NIDA Participation in PA-20-135. See Notice NOT-DA-20-061.
June 5, 2020 - Notice of NIDCD's Participation in PA-20-13. See Notice NOT-DC-20-010.
June 5, 2020 - Notice of NIA Participation in PA-20-135. See Notice NOT-AG-20-036.
May 21, 2020 - Reissue of Parent Announcements (PA-18-589, PA-18-590, PA-18-591, and PA-18-592) and the Urgent (PA-18-935) and Emergency (PA-20-135) Competitive Revision FOAs is Underway - Continue to use the Current Announcements and Forms Packages Until Reissuance. See Notice NOT-OD-20-110.
April 27, 2020 - Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials. See Notice NOT-HL-20-782.
April 27, 2020 - Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). See Notice NOT-RM-20-015.
April 21, 2020 - Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs. See Notice NOT-TR-20-028.
April 14, 2020 - Notice of Common Fund’s Participation in PA-20-135. See Notice NOT-RM-20-016.
April 13, 2020 - Notice of Participation of NIAAA in PA-20-135. See Notice NOT-AA-20-007.
April 10, 2020 - Notice of Early Expiration of NOT-ES-20-015. See Notice NOT-ES-20-019.
April 10, 2020 - Notice of Early Expiration of 'Notice of Special Interest (NOSI) regarding the NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed)'. See Notice NOT-ES-20-016.
April 10, 2020 - NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed). See Notice NOT-ES-20-017.
April 10, 2020 - Notice of Special Interest (NOSI): Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19). See Notice NOT-EB-20-008.
April 9, 2020 - Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus. See Notice NOT-TR-20-017.
April 9, 2020 - Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19). See Notice NOT-ES-20-015.
April 8, 2020 - Notice of NCATS' Participation in PA-20-135. See Notice NOT-TR-20-013.
March 26, 2020 - Notice of Special Interest: NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed). See Notice NOT-ES-20-014.
March 25, 2020 - Notice of Early Expiration of 'Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV),' NOT-AI-20-030. See Notice NOT-AI-20-040.
March 25, 2020 - Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). See Notice NOT-AI-20-034.
March 18, 2020 - Notice of NIBIB's Participation in PA-20-135. See Notice NOT-EB-20-003.

PA-20-135

None

See Section III. 3. Additional Information on Eligibility.

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.121, 93.213, 93.393, 93.394, 93.395, 93.396, 93.399, 93.172, 93.855, 93.865, 93.847, 93.113, 93.142, 93.143, 93.859, 93.307, 93.286, 93.350, 93.273, 93.310 , 93.866, 93.173, 93.879, 93.242, 93.361, 93.867, 93.846

The National Institutes of Health (NIH) hereby notify the applicant community that funds may be available for applications based on a presidentially declared disaster under the Stafford Act, a public health emergency declared by the Secretary, HHS, or other local, regional or national disaster. Applications in response to Emergency Notices of Special Interest (NOSIs) will be routed directly to the NIH awarding component signed on to the Emergency NOSI.

Only applications submitted in response to an Emergency NOSI published by an IC will be allowed to apply to this FOA.

March 10, 2020

Open dates may vary by awarding IC. See Emergency Notice of Special Interest (NOSI) for applicable Application Due Dates.

Not Applicable

See the Emergency Notice of Special Interest (NOSI) for any applicable Application Due Dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Not Applicable

See Emergency Notice of Special Interest (NOSI) for information on start dates associated with specific needs.

March 10, 2023

Not Applicable

It is critical that applicants follow the instructions in the Application Guide (SF424 (R&R) Application Guide, as appropriate) except where instructed to do otherwise (in this FOA or in a Notice from the NIH Guide for Grants and Contracts). Conformance to all requirements (both in the Application Guide and the FOA) is required and strictly enforced. Applicants must read and follow all application instructions in the Application Guide as well as any program-specific instructions noted in Section IV. When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions. Applications that do not comply with these instructions may be delayed or not accepted for review.

There are several options available to submit your application through Grants.gov to NIH and Department of Health and Human Services partners. You must use one of these submission options to access the application forms for this opportunity.

Use the NIH ASSIST system to prepare, submit and track your application online.
Use an institutional system-to-system (S2S) solution to prepare and submit your application to Grants.gov and eRA Commons to track your application. Check with your institutional officials regarding availability.
Use Grants.gov Workspace to prepare and submit your application and eRA Commons to track your application.

Table of Contents

Part 1. Overview Information
Part 2. Full Text of the Announcement
Section I. Funding Opportunity Description
Section II. Award Information
Section III. Eligibility Information
Section IV. Application and Submission Information
Section V. Application Review Information
Section VI. Award Administration Information
Section VII. Agency Contacts
Section VIII. Other Information

Section I. Funding Opportunity Description

Applications for Emergency Competitive Revisions will be routed directly to the NIH awarding component listed on the NoA of the most recent parent award.

Only applications submitted in response to an Emergency Notice of Special Interest (NOSI) published by an IC will be allowed to apply to this FOA.

The funding instrument will be the same as the parent award.

Grant: A support mechanism providing money, property, or both to an eligible entity to carry out an approved project or activity.

Cooperative Agreement: A support mechanism used when there will be substantial Federal scientific or programmatic involvement. Substantial involvement means that, after award, NIH scientific or program staff will assist, guide, coordinate, or participate in project activities. See Section VI.2 for additional information about the substantial involvement for this FOA.

Revision applications to active NIH awards. The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types.

Optional: Accepting applications that either propose or do not propose clinical trial(s)

The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Application budgets are not limited but need to reflect the actual needs of the proposed project.

The project and budget periods must be within the currently approved project period for the existing parent award. The parent award must be active when the application is submitted.

NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this FOA.

1. Eligible Applicants

All organizations administering an eligible parent award may apply for a supplement under this announcement.

Higher Education Institutions

Public/State Controlled Institutions of Higher Education
Private Institutions of Higher Education

The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:

Hispanic-serving Institutions
Historically Black Colleges and Universities (HBCUs)
Tribally Controlled Colleges and Universities (TCCUs)
Alaska Native and Native Hawaiian Serving Institutions
Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)

Nonprofits Other Than Institutions of Higher Education

Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)
Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)

For-Profit Organizations

Small Businesses
For-Profit Organizations (Other than Small Businesses)

Governments

State Governments
County Governments
City or Township Governments
Special District Governments
Indian/Native American Tribal Governments (Federally Recognized)
Indian/Native American Tribal Governments (Other than Federally Recognized)
Eligible Agencies of the Federal Government
U.S. Territory or Possession

Other

Independent School Districts
Public Housing Authorities/Indian Housing Authorities
Native American Tribal Organizations (other than Federally recognized tribal governments)
Faith-based or Community-based Organizations
Regional Organizations
Non-domestic (non-U.S.) Entities (Foreign Institutions)

Foreign Institutions

Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Applicant Organizations

Applicant organizations must complete and maintain the following registrations as described in the SF 424 (R&R) Application Guide to be eligible to apply for or receive an award. Since competitive revisions are made against active grants and cooperative agreements, many of these registrations may already be in place. All registrations must be completed prior to the application being submitted. Registration can take 6 weeks or more, so applicants should begin the registration process as soon as possible. The NIH Policy on Late Submission of Grant Applications states that failure to complete registrations in advance of a due date is not a valid reason for a late submission.

Dun and Bradstreet Universal Numbering System (DUNS) - All registrations require that applicants be issued a DUNS number. After obtaining a DUNS number, applicants can begin both SAM and eRA Commons registrations. The same DUNS number must be used for all registrations, as well as on the grant application.
System for Award Management (SAM) (formerly CCR) – Applicants must complete and maintain an active registration, which requires renewal at least annually. The renewal process may require as much time as the initial registration. SAM registration includes the assignment of a Commercial and Government Entity (CAGE) Code for domestic organizations which have not already been assigned a CAGE Code. In the case of Emergency awards, if the applicant is unable to comply with the requirement to complete and maintain SAM registration at the time of application submission, contact the agency immediately.
o NATO Commercial and Government Entity (NCAGE) Code – Foreign organizations must obtain an NCAGE code (in lieu of a CAGE code) in order to register in SAM.
eRA Commons - Applicants must have an active DUNS number to register in eRA Commons. Organizations can register with the eRA Commons as they are working through their SAM or Grants.gov registration, but all registrations must be in place by time of submission. eRA Commons requires organizations to identify at least one Signing Official (SO) and at least one Program Director/Principal Investigator (PD/PI) account in order to submit an application.
Grants.gov – Applicants must have an active DUNS number and SAM registration in order to complete the Grants.gov registration. Grants.gov registration is only required if you plan to submit using the 'Electronic Application Submission through Grants.gov' option.

Program Directors/Principal Investigators (PD(s)/PI(s))

All PD(s)/PI(s) must have an eRA Commons account. PD(s)/PI(s) should work with their organizational officials to either create a new account or to affiliate their existing account with the applicant organization in eRA Commons.If the PD/PI is also the organizational Signing Official, they must have two distinct eRA Commons accounts, one for each role. Obtaining an eRA Commons account can take up to 2 weeks.

Eligible Individuals (Program Director/Principal Investigator)

Individual(s) must hold an active grant or cooperative agreement, and the research proposed in the supplement must be accomplished within the competitive segment of the active award. Individuals are encouraged to work with their organizations to develop applications for support.
For supplements to parent awards that include multiple PDs/PIs, the supplement may be requested by any or all of the PDs/PIs (in accordance with the existing leadership plan) and submitted by the awardee institution of the parent award. Do not use this competitive revision application to add, delete, or change the PDs/PIs listed on the parent award. Visit the Multiple Program Director/Principal Investigator Policy in the SF424 (R&R) Application Guide for more information.

This FOA does not require cost sharing as defined in the NIH Grants Policy Statement.

3. Additional Information on Eligibility

Applicant organizations may submit more than one application, provided that each is sufficiently distinct from any other application currently under consideration by the awarding NIH Institute or Center.

Section IV. Application and Submission Information

Applicants must prepare applications using current forms in accordance with the Application Guide.

The application forms package specific to this opportunity must be accessed through ASSIST, Grants.gov Workspace or an institutional system-to-system solution. Links to apply using ASSIST or Grants.gov Workspace are available in Part 1 of this FOA. See your administrative office for instructions if you plan to use an institutional system-to-system solution.

2. Content and Form of Application Submission

All applications must be submitted electronically using one of the submission methods listed in Part 1 of this FOA and must be in response to an Emergency Notice of Special Interest (NOSI) that refers to this FOA.

It is critical that applicants follow the instructions for their submission option (SF424 (R&R) Application Guide, as appropriate) except where instructed in this funding opportunity announcement to do otherwise. Conformance to documented requirements is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.

All page limitations applicable to the parent award as described in the Application Guide and the Table of Page Limits for the activity code of the parent award must be followed, except where instructed otherwise in the Emergency Notice of Special Interest (NOSI).

Application Submission

Instructions for Electronic Application Submission through Grants.gov

The following section supplements the instructions found in the SF424 (R&R) Application Guide and should be used for preparing an application to this FOA.